Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
瑞戈非尼与卡博替尼作为索拉非尼治疗后不可切除肝细胞癌的二线治疗：匹配调整间接比较分析
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-021-03602-w
Casadei-Gardini, Andrea; Rimassa, Lorenza; Rimini, Margherita; Yoo, Changhoon; Ryoo, Baek-Yeol; Lonardi, Sara; Masi, Gianluca; Kim, Hyung-Don; Vivaldi, Caterina; Ryu, Min-Hee; Rizzato, Mario Domenico; Salani, Francesca; Bang, Yeonghak; Pellino, Antonio; Catanese, Silvia; Burgio, Valentina; Cascinu, Stefano; Cucchetti, Alessandro
